Popular on TelAve
- Althea Gibson Honored as Final Release in U.S. Mint's American Women Quarters Program - 154
- Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
- TradingHabits.com Launches to Support Day Trader Well-being
- 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
- BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
- Americans Are Trading Offices for Beaches: How Business Ownership Enables the Ultimate Location Freedom
- Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
- Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
- WHES Retains BloombergNEF Tier 1 Ranking for Sixth Consecutive Quarter
- Boston Industrial Solutions' Natron® DC Series Ink Has Had an Upgrade!
Similar on TelAve
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
- Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
- $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
- $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
- U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
- Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform
- MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna
- New You Smile Dental Implant Center Expands Office
Gold Standard Diagnostics Launches AIX1000 2.1® with Extra High Titer RPR Testing
TelAve News/10880426
Gold Standard Diagnostics receives FDA clearance for AIX1000® 2.1-- now with extra high titer capabilites.
DAVIS, Calif. - TelAve -- Gold Standard Diagnostics Launches AIX1000 2.1® with Extra High Titer RPR Testing and Enhanced Workflow Features
Gold Standard Diagnostics is proud to announce the release of AIX1000® Version 2.1, a major upgrade to its flagship RPR automation platform. This release introduces extra high titer capability, now supporting screens and titers up to 1:2048, a breakthrough in syphilis detection and treatment monitoring—especially for late-stage and Neurosyphilis cases.
The expanded titer range empowers laboratories to more accurately track antibody levels over time, improving clinical decision-making and supporting public health initiatives focused on syphilis control and eradication.
This AIX1000® 2.1 upgrade is the first and only FDA cleared automated test system to meet the 2024 CDC Laboratory Recommendations for Syphilis Testing "Recommendation for endpoint titers. Endpoint titers (the highest dilution yielding a reactive result) should be determined and clearly reported when testing serum with nontreponemal (lipoidal antigen) assays that detect antibodies to lipoidal antigens (i.e., rapid plasma reagin and Venereal Disease Research Laboratory).1"
More on TelAve News
"Extra high titer testing is vital for improving detection of late-stage or Neurosyphilis cases, tracking the effectiveness of syphilis treatment over time, and supporting public health need for endpoint titers" said Sean Hoesterey, Vice President of Commercial Operations, at Gold Standard Diagnostics.
In addition to the enhanced titer range, AIX1000® 2.1 delivers a suite of workflow and data management improvements designed to streamline operations and improve clarity:
The AIX1000® 2.1 software is fully compatible with:
Gold Standard Diagnostics was the first FDA cleared automated RPR testing platform in 2015 and continues to lead innovation in automated RPR testing, delivering precision, speed, and reliability to clinical laboratories worldwide.
More on TelAve News
For more information, email Gsd.info@us.goldstandarddiagnostics.com or contact your GSD representative.
For media inquiries, please contact:
Sarah Siegel
Marketing Communications Specialist
sarah.siegel@us.goldstandarddiagnostics.com
(707) 239-2863
1Papp J. R. et al. 2024. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep., 73(No. RR-1):1–32. DOI: http://dx.doi.org/10.15585/mmwr.rr7301a1 (https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fdx.doi.org%2F10.15585%2Fmmwr.rr7301a1&data=05%7C02%7C%7C146e2af518cb40e2b79108de0c1bf10a%7C19e5846425f4437da9d21182f30f78eb%7C0%7C0%7C638961511313225122%7CUnknown%7CTWFpbGZsb3d8eyJFbX...).
Gold Standard Diagnostics is proud to announce the release of AIX1000® Version 2.1, a major upgrade to its flagship RPR automation platform. This release introduces extra high titer capability, now supporting screens and titers up to 1:2048, a breakthrough in syphilis detection and treatment monitoring—especially for late-stage and Neurosyphilis cases.
The expanded titer range empowers laboratories to more accurately track antibody levels over time, improving clinical decision-making and supporting public health initiatives focused on syphilis control and eradication.
This AIX1000® 2.1 upgrade is the first and only FDA cleared automated test system to meet the 2024 CDC Laboratory Recommendations for Syphilis Testing "Recommendation for endpoint titers. Endpoint titers (the highest dilution yielding a reactive result) should be determined and clearly reported when testing serum with nontreponemal (lipoidal antigen) assays that detect antibodies to lipoidal antigens (i.e., rapid plasma reagin and Venereal Disease Research Laboratory).1"
More on TelAve News
- Canterbury Hotel Group Announces the Opening of the TownePlace Suites by Marriott Portland Airport
- Heritage at South Brunswick's Resort-Style Amenities for Any Age and Every Lifestyle
- T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
- Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)
- New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
"Extra high titer testing is vital for improving detection of late-stage or Neurosyphilis cases, tracking the effectiveness of syphilis treatment over time, and supporting public health need for endpoint titers" said Sean Hoesterey, Vice President of Commercial Operations, at Gold Standard Diagnostics.
In addition to the enhanced titer range, AIX1000® 2.1 delivers a suite of workflow and data management improvements designed to streamline operations and improve clarity:
- Reflex Runs After Worklist Completion
- Automatic Next Actions
- Improved LIS Communication – Easier for LIS systems to interpret run data
- Enhanced Data Analysis
- Faster Backup and Restore
- Bleach Maintenance Support – Compatible with the GSD Bleach (Cat # SHW-20)
- Optional Text and Email Notifications for Errors
The AIX1000® 2.1 software is fully compatible with:
- Gold Standard Diagnostics Rapid Plasma Reagin (RPR) Test System (Cat # GSD01-1600)
- GSD Bleach (Cat # SHW-20)
- GSD RPR Diluent (Cat # GSD01-1600-DIL)
Gold Standard Diagnostics was the first FDA cleared automated RPR testing platform in 2015 and continues to lead innovation in automated RPR testing, delivering precision, speed, and reliability to clinical laboratories worldwide.
More on TelAve News
- BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
- FittingPros Launches Industry's First Data-Driven Golf Club Fitting Directory
- Local Fiber Announces Graduation from Samsung Next Startup Program, Marks New Phase of Growth
- Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
- "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
For more information, email Gsd.info@us.goldstandarddiagnostics.com or contact your GSD representative.
For media inquiries, please contact:
Sarah Siegel
Marketing Communications Specialist
sarah.siegel@us.goldstandarddiagnostics.com
(707) 239-2863
1Papp J. R. et al. 2024. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep., 73(No. RR-1):1–32. DOI: http://dx.doi.org/10.15585/mmwr.rr7301a1 (https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fdx.doi.org%2F10.15585%2Fmmwr.rr7301a1&data=05%7C02%7C%7C146e2af518cb40e2b79108de0c1bf10a%7C19e5846425f4437da9d21182f30f78eb%7C0%7C0%7C638961511313225122%7CUnknown%7CTWFpbGZsb3d8eyJFbX...).
Source: Gold Standard Diagnostics, LLC
0 Comments
Latest on TelAve News
- Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
- Oklahoma and Starlink Local Installers getting it done!
- Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand
- Signature Smiles Dental Group Unveils New User-Friendly Website
- CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
- QwickContractReview.com Launches $19 Contract Review Service to Protect Consumers from Hidden Contract Risks
- 100% Bonus Depreciation Places New Spotlight on Off The Hook Yacht Sales Inc. (N Y S E: OTH) as a Major Player in the $57 Billion U.S. Marine Market
- CNCPW Benchmarks Global Industry Standards: Integrating SEC Compliance with 3 Million TPS Architecture for Institutional Infrastructure
- The Patina Collective & Artist Jesse Draxler Debut "The Machine of Loving Grace"
- Smile! Dental Center Named 2025 "Best Dentist" in North Pittsburgh, Celebrating High-Tech Care and Heartfelt Service
- Dr. Johnny Shanks, As Seen on TV, Announces 20% Off Dental Implant Treatments | Tennessee's Leading All-on-X Provider
- Star Sleep & Wellness Expands to Pearland, Texas — Bringing Life-Changing Sleep Care to More Communities
- Fort Lauderdale Dentist Dr. Taskonak & IN A DAY SMILE Receive Emmy Nomination for Life-Changing Documentary "The Weight of a Smile"
- Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
- BET and Soul Train Awards - GONE! - Introducing The World Hip Hop Awards
- Australian Aboriginal Cultural Immersions and First Nations Workshops
- Uk Financial Ltd Featured In New York Business Now — 2019 Gold-Backed Bitcoin Prediction Now Becomes SEC Security Token Filing
- MROVI Trailer Parts Launches Its Own Tire Brand: Introducing MROVI Tires and the New Didgori Trail Tread
- ATL Free WiFi Brings Free Public Internet to Atlanta's BeltLine and Local Neighborhoods
- AI, Fintech, and Cybersecurity Divisions Ignite High-Margin Growth: IQSTEL, Inc. (N A S D A Q: IQST)